Quantitation of minimal residual disease in multiple myeloma using an allele-specific real-time PCR assay

Author： Rasmussen T.   Poulsen T.S.   Honore L.   Johnsen H.E.  

Publisher： Elsevier

ISSN： 0301-472X

Source： Experimental Hematology, Vol.28, Iss.9, 2000-09, pp. : 1039-1045

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Monitoring of Minimal Residual Disease in Patients with Multiple Myeloma

By Fenk Roland   Haas Rainer   Kronenwett Ralf  

Hematology, Vol. 9, Iss. 1, 2004-02 ,pp. : 17-33

Maney Publishing

Access to resources Recommend Favorite

Minimal residual disease in multiple myeloma: Benefits of flow cytometry

By  

International Journal Of Laboratory Hematology, Vol. 40, Iss. 1, 2018-02 ,pp. : 12-20

John Wiley & Sons Inc

Access to resources Recommend Favorite

Minimal residual disease quantification in childhood acute lymphoblastic leukemia by real-time polymerase chain reaction using the SYBR green dye

By Li A.-H.   Forestier E.   Rosenquist R.   Roos G.  

Experimental Hematology, Vol. 30, Iss. 10, 2002-10 ,pp. : 1170-1177

Elsevier

Access to resources Recommend Favorite

Quantification using real-time PCR technology: applications and limitations

By Klein D.  

Trends in Molecular Medicine, Vol. 8, Iss. 6, 2002-06 ,pp. : 257-260

Elsevier

Access to resources Recommend Favorite

Real-time polymerase chain reaction in multiple myeloma - Quantitative analysis of tumor contamination of stem cell harvests

By Ladetto M.   Omede P.   Sametti S.   Donovan J.W.   Astolfi M.   Drandi D.   Volpato F.   Giaccone L.   Giaretta F.   Palumbo A.   Bruno B.   Pileri A.   Gribben J.G.   Boccadoro M.  

Experimental Hematology, Vol. 30, Iss. 6, 2002-06 ,pp. : 529-536

Elsevier

Access to resources Recommend Favorite